Treated Diabetic Retinopathy Rare in Children With T1DM

Share this content:
Treated Diabetic Retinopathy Rare in Children With T1DM
Treated Diabetic Retinopathy Rare in Children With T1DM

WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- Treated diabetic retinopathy (DR) is extremely rare among children with type 1 diabetes, according to research published online Oct. 7 in Diabetes Care.

Giovanna Beauchamp, M.D., from the University of Florida in Gainesville, and colleagues used data from the T1D Exchange Clinic Registry to examine how often treatable DR was reported among young people. Information was collected about treatment for DR for 12,535 patients aged <21 years who were not pregnant.

The researchers found that 45 subjects (0.36 percent) self-reported treatment for DR. Of those 45 subjects reporting DR and for whom an ophthalmologist report was available or for whom treatment history was known (12 and 33, respectively), none had actually received DR treatment.

"The negligible yield of possibly treatable and treated eye lesions compounded by the considerable financial burden associated with eye exams suggests that current guidelines for DR screening in youth with type 1 diabetes may not be cost-effective," the authors write. "While additional studies are needed before firm recommendations can be made, liberalization of pediatric DR screening guidelines may be justified and could allow for utilization of saved resources in areas historically lacking support such as mental health and nutrition counseling."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »